HIT — Health In Tech Cashflow Statement
0.000.00%
Last trade - 00:00- $36.31m
- $28.73m
- $19.49m
Annual cashflow statement for Health In Tech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.243 | 3.96 | 0.67 |
| Amortisation | |||
| Deferred Taxes | |||
| Non-Cash Items | 1.22 | -2.23 | 0.901 |
| Discontinued Operations | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -0.201 | -0.668 | 0.157 |
| Change in Accounts Receivable | |||
| Change in Prepaid Expenses | |||
| Change in Accrued Expenses | |||
| Change in Payable / Accrued Expenses | |||
| Change in Taxes Payable | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 0.783 | 1.53 | 2.18 |
| Capital Expenditures | -1.22 | -1.14 | -0.901 |
| Software Development Costs | |||
| Other Investing Cash Flow Items | — | -0.8 | 0.064 |
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -1.22 | -1.94 | -0.837 |
| Financing Cash Flow Items | 0 | -0.262 | -1.98 |
| Other Financing Cash Flow | |||
| Total Cash Dividends Paid | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 1.88 | 1.34 | 4.09 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 1.44 | 0.928 | 5.43 |